The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia Article

Chaiworapongsa, Tinnakorn, Romero, Roberto, Whitten, Amy E et al. (2016). The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia . Journal of Maternal-Fetal and Neonatal Medicine, 29(8), 1214-1228. 10.3109/14767058.2015.1048431

Open Access

cited authors

  • Chaiworapongsa, Tinnakorn; Romero, Roberto; Whitten, Amy E; Korzeniewski, Steven J; Chaemsaithong, Piya; Hernandez-Andrade, Edgar; Yeo, Lami; Hassan, Sonia S

sustainable development goals

authors

publication date

  • April 17, 2016

published in

keywords

  • Angiogenic
  • Anti-angiogenic factors
  • ENDOTHELIAL GROWTH-FACTOR
  • FACTOR RECEPTOR-1 CONCENTRATION
  • FETAL-GROWTH
  • FUNDAL HEIGHT-MEASUREMENT
  • GESTATIONAL-AGE INFANTS
  • HIGH-RISK PREGNANCIES
  • LATE-ONSET PREECLAMPSIA
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Science & Technology
  • TYROSINE KINASE-1 SFLT-1
  • UMBILICAL ARTERY
  • UTERINE ARTERY DOPPLER
  • intrauterine growth restriction (IUGR)
  • placental growth factor
  • pregnancy
  • sflt-1
  • soluble endoglin
  • soluble vascular endothelial growth factor receptor-1
  • umbilical artery Doppler
  • uterine artery Doppler

Digital Object Identifier (DOI)

start page

  • 1214

end page

  • 1228

volume

  • 29

issue

  • 8